We are creating industry leading products utilizing our revolutionary inhalation and oral dosage technologies both on our own as well as through collaborations with top-tier partners.
MicroDose’s pipeline is well balanced in terms of stage of development, risk, and therapeutic category and Includes both small and large molecules addressing unmet needs in a variety of diseases, including:
- Respiratory (including Asthma and COPD);
- Diabetes and Hypertension; and
Below lists some of our pipeline of both partnered and proprietary products and their respective stages of development: